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Abstract
Human African Trypanosomiasis is a devastating disease caused by the parasite Trypanosoma brucei. Trypanosomes live
extracellularly in both the tsetse fly and the mammal. Trypanosome surface proteins can directly interact with the host
environment, allowing parasites to effectively establish and maintain infections. Glycosylphosphatidylinositol (GPI)
anchoring is a common posttranslational modification associated with eukaryotic surface proteins. In T. brucei, three GPI-
anchored major surface proteins have been identified: variant surface glycoproteins (VSGs), procyclic acidic repetitive
protein (PARP or procyclins), and brucei alanine rich proteins (BARP). The objective of this study was to select genes
encoding predicted GPI-anchored proteins with unknown function(s) from the T. brucei genome and characterize the
expression profile of a subset during cyclical development in the tsetse and mammalian hosts. An initial in silico screen of
putative T. brucei proteins by Big PI algorithm identified 163 predicted GPI-anchored proteins, 106 of which had no known
functions. Application of a second GPI-anchor prediction algorithm (FragAnchor), signal peptide and trans-membrane
domain prediction software resulted in the identification of 25 putative hypothetical proteins. Eighty-one gene products
with hypothetical functions were analyzed for stage-regulated expression using semi-quantitative RT-PCR. The expression of
most of these genes were found to be upregulated in trypanosomes infecting tsetse salivary gland and proventriculus
tissues, and 38% were specifically expressed only by parasites infecting salivary gland tissues. Transcripts for all of the genes
specifically expressed in salivary glands were also detected in mammalian infective metacyclic trypomastigotes, suggesting
a possible role for these putative proteins in invasion and/or establishment processes in the mammalian host. These results
represent the first large-scale report of the differential expression of unknown genes encoding predicted T. brucei surface
proteins during the complete developmental cycle. This knowledge may form the foundation for the development of future
novel transmission blocking strategies against metacyclic parasites.
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Introduction
Sleeping Sickness, or Human African Trypanosomiasis (HAT),
is a fatal parasitic disease transmitted by the bite of an infected
tsetse (Glossina spp.) fly. The disease agents are the extracellular
protozoan parasites belonging to the Trypanosoma brucei species
complex. It is estimated that 60 million people in 36 African
nations are at risk for HAT. The same parasite species complex
also infects animals causing nagana, an economically important
disease of livestock in Africa. There are no mammalian vaccines
for disease control and the drugs used for chemotherapy have
major adverse effects, are difficult to administer and have
decreased efficacy in light of the emergence of parasite drug
resistance. A number of disease control strategies, mainly focused
on vector control and treatment of infections, have been applied.
These are often successful in the short term, although a sustainable
long-term solution remains unidentified.
African trypanosomes undergo multiple differentiation steps as
they complete their life cycle in the challenging environments of
the mammalian and invertebrate hosts. Trypanosomes circulating
in the mammalian bloodstream (bloodstream form, BSF) are
found as either long slender forms that perpetuate the infection in
the mammal, or as short stumpy forms that are infective to the
tsetse fly. In the mammalian host, BSF parasites evade the
adaptive immune system by changing their surface coat molecules
in a process known as antigenic variation [1]. Antigenic variation
has effectively prevented the development of mammalian vaccines
to date.
In the tsetse flies, a strong immune response apparently clears
the parasites in the majority (over 95%) of challenged tsetse [2] but
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contribute to disease transmission. Once acquired in an infected
bloodmeal, trypanosomes undergo several stages of differentiation
in the fly before they are transmissible to the mammalian host [3].
In the midgut, the stumpy BSF parasites differentiate to the
procyclic form (PF) parasites. Although the majority of flies can
clear parasite infections at this stage [2], in flies where the PF cells
survive, trypanosomes migrate anteriorly to the proventriculus,
and differentiate initially into the mesocyclic trypomastigote, then
long and short epimastigotes. It is thought that only the short
epimastigotes can invade the salivary glands, where they attach
and differentiate ultimately giving rise to the free mammalian
infective metacyclic trypomastigotes (MCF), which are transferred
to the mammalian host in saliva as the infected fly blood feeds.
Only the BSF and PF developmental stages of T. brucei can be
maintained in culture in vitro. The remaining developmental stages
of the parasite can only be maintained in tsetse, making the access
to and evaluation of these life stages difficult.
The genomes of several related kinetoplastid parasites have
been published, including T. brucei brucei and Trypanosoma brucei
gambiense [4–8]. Improved technologies such as RNA sequencing
have identified over 1,000 new transcripts in T. b. brucei [9].
Particularly relevant for disease control tools are surface expressed
proteins that interact with the host environment, and specifically
with the host immune system. Protein features that are suggestive
of surface expression are associated signal peptides, trans-
membrane domains, and glycosylphosphatidylinositol (GPI) an-
chor attachment domains. Many GPI-anchored proteins in
mammalian systems have been shown or predicted to have
hydrolytic activity, or serve as receptors or adhesion molecules,
while some are suggested to be involved in trans-membrane
signaling or membrane trafficking [10,11].
The two well-studied GPI-anchored surface coat proteins of T.
brucei are the variant surface glycoproteins (VSGs) and procyclins,
expressed by the BSF and PF cells, respectively. The VSG coat of
the BSF trypanosome allows the parasite to evade the adaptive
immune response and therefore persist in the mammalian host.
The procyclins were initially thought to shield PF parasites from
the digestive enzymes of the fly midgut [12], but procyclin-null
mutant trypanosomes were subsequently found to be capable of
infecting tsetse [13]. BARP, a third GPI-anchored surface protein
family identified in T. brucei [14] is expressed by immature salivary
gland stages [15]. Functional assessment of the BARP proteins
have not yet been described, so it is unknown if trypanosome
survival or maturation in the salivary gland environment would be
influenced in their absence. The serum resistance associated
protein (SRA), which allows the survival of Trypanosoma brucei
rhodesiense in the human host was recently determined to be GPI-
anchored [16], demonstrating the role of GPI-anchored proteins
in the host-range of this pathogen. Additionally, a sub-unit of the
transferrin receptor (ESAG6) was also demonstrated to be GPI-
anchored [17], and work continues on the characterization of this
molecule.
Here, we report on the differential expression of transcripts
corresponding to putative GPI anchored proteins with unknown
functions in T. brucei. The selected genes were initially identified in
silico using the Big PI and subsequently by the FragAnchor GPI-
prediction algorithms. The signal peptide and trans-membrane
domains of the putative proteins were also analyzed in silico. Gene
expression data was obtained from parasites infecting the tsetse
and mammalian hosts. We discuss the implications of the observed
transcript expression profiles with regard to parasite survival and
transmission processes, with consideration of the mammalian
infective metacyclic trypomastigote.
Materials and Methods
Ethics statement
This experiment was carried out in strict accordance with the
recommendations in the Office of Laboratory Animal Welfare at
the National Institutes of Health and the Yale University
Institutional Animal Care and Use Committee. The experimental
protocol was reviewed and approved by the Yale University
Institutional Animal Care and Use Committee (Protocol 2011-
07266).
In silico analysis
Genes encoding putative GPI anchor attachment domains were
identified in silico and manually curated during the annotation of
the first publicly available T. brucei brucei strain 927 genome
sequence [4]. GPI anchor predictions were made by the
consortium using the publicly available software Big-PI Predictor
(http://mendel.imp.ac.at/gpi/gpi_server.html) [18]. The known
GPI anchored protein families, such as VSG and procyclin, were
removed from the resulting list. A second program, FragAnchor
(http://navet.ics.hawaii.edu/,fraganchor/NNHMM/NNHMM.
html), was applied to genome annotation data from version 4 of
the T. brucei genome [19]. Non-VSG, non-procyclin genes were
categorized as hypothetical, hypothetical conserved, or annotated
with known functions, according to the parameters set by the T.
brucei genome consortium. Interpro domains associated to these
genes were retrieved from TriTrypDB (http://tritrypdb.org/
tritrypdb/). Gene products with less than 36% identity to a match
in the public databases were considered hypothetical proteins,
having no known function. When protein identity levels of 36%
and higher to other hypothetical proteins were detected, the
protein was considered hypothetical conserved. Hypothetical
conserved genes, which were predicted to have homologs within
the T. brucei genome, were further classified as hypothetical gene
family members. Homology to other kinetoplastid species was
Author Summary
Human African Trypanosomiasis (HAT) is a fatal disease
caused by African trypanosomes and transmitted by an
infected tsetse fly. Presently, there are no vaccines to
prevent mammalian infections. Proteins expressed on the
trypanosome surface can influence the host environment
and allow for their transmission. Potentially accessible to
the adaptive immune systems of vertebrate hosts, these
proteins could serve as future vaccine targets. Identifica-
tion and characterization of these currently unknown
proteins can help us develop strategies to alter the host
environment, making it inhospitable for the parasite,
thereby reducing disease transmission. While there is
extensive knowledge about trypanosome development in
the mammalian host, less is known about the molecular
events in the tsetse fly, particularly the salivary gland
stages. We used an in silico approach to identify putative
surface proteins from the known genome sequence of
Trypanosoma brucei, and we describe the stage specific
expression of these genes during development in the
tsetse fly and mammalian host. Our findings show that a
majority of unknown transcripts encoding predicted
surface proteins are expressed by the parasites infecting
tsetse salivary glands. These data will help focus future
investigations into transmission-blocking approaches tar-
geting the expressed antigens of trypanosomes infecting
tsetse salivary glands.
T. brucei Differential Gene Expression
www.plosntds.org 2 June 2012 | Volume 6 | Issue 6 | e1708determined using either existing data on the Sanger T. brucei
website (for Leishmania major and Trypanosoma cruzi, (TriTryp)), or by
using the omniBLAST protein search function on the Sanger
GeneDB website (http://www.genedb.org). Signal peptide and
cleavage site predictions were determined by SignalP (http://
www.cbs.dtu.dk/services/SignalP/) [20]. Trans-membrane pre-
dictions were made using DAS Software (http://www.sbc.su.se/
,miklos/DAS/) [21]. Predictions of glycosylation sites were
performed using the NetNGlyc 1.0 (http://www.cbs.dtu.dk/
services/NetNGlyc/) and NetOGlyc Servers (http://www.cbs.
dtu.dk/services/NetOGlyc/) [22]. All prediction software is
publically available on the internet.
Parasite strains and tsetse infections
The parasite strains used were T. b. brucei RUMP 503 and T. b.
rhodesiense YTAT 1.1. For gene expression analysis, RNA was
prepared from BSF T. b. rhodesiense expanded in rats. Trypano-
somes were harvested from infected blood at peak parasitemia
using DEAE cellulose chromatography [23,24]. For fly infections,
BSF T. b. brucei expanded in rats were cryopreserved for
subsequent use. Newly emerged male flies from the Glossina
morsitans morsitans colony maintained in the Yale insectary received
2610
6–2610
7/mL T. b. brucei parasites in defibrinated bovine
blood meal diet using an artificial membrane system [25]. After a
single parasite challenge, flies were maintained on defibrinated
bovine blood provided every other day.
Tissue dissections, RNA isolation and cDNA generation
Flies were dissected after a minimum of 40 days post infection
(dpi) and 72 hrs after their last blood meal. Salivary gland (SG)
infection status was microscopically determined on a Zeiss
Axiostar Plus light microscope at 4006. Infected SG, proventric-
ulus (PV) and midgut (MG) tissues from the same flies were
collected in Trizol, vortexed, and midguts were homogenized
immediately. Metacyclic form (MCF) parasites were obtained by
collecting the blood remaining on the feeding apparatus after flies
with mature SG infections were fed. Blood was collected in PSG
buffer (0.04 M Na2HPO4 2H 20, 0.006 M NaH2PO4 2H 2O, 0.07
M NaCl, to pH 8.0 with 1 M H2PO4), centrifuged 5 min. at
3000 rpm, and the pellet was resuspended in Trizol and stored at
220uC until RNA isolation. Total RNA was isolated from fly
tissues and infected blood using Trizol extraction, according to
manufacturer’s instructions (catalog no. 15596-026, Invitrogen,
California). Genomic DNA was removed by incubation with
DNAse I, according to manufacturer’s protocol (catalog
no. 04716728001, Roche, Indiana). Reverse transcription was
performed according to manufacturers instructions for oligo d(T)
primed reactions (SuperScript II Reverse Transcriptase, catalog
no. 18064-014; RNaseOUT, catalog no. 10777-019, Invitrogen,
California).
Primer design and PCR amplification
Nucleotide sequences for all experimental genes were obtained
from the publicly available genome reference at the Sanger Institute
(http://www.genedb.org/Homepage/Tbruceibrucei927). Primer se-
quences were identified by using the OligoPerfect
TMDesigner primer
design tool (http://tools.invitrogen.com/content.cfm?pageid=9716)
(see Table S1). All primer sets were used in a PCR amplification
reaction with gDNA to confirm that they amplified a single gene
fragment of the expected size. PCR amplification conditions were:
2 minuteshot start at 95uC,32cyclesat(95uC for 45 s, 53uC for 45 s,
74uCf o r1m i n )a n d7 4 uC for 6 min. Primersused to amplifyprocyclin
transcripts were designed to recognize both EP and GPEET procyclin.
Semi-quantitative RT-PCR
The trypanosome structural gene alpha-tubulin was used for
normalization of experimental cDNAs: trypanosome infected
tsetse SG, PV, and MG, as well as BSF obtained from infected
rats. Five and ten-fold serial dilutions of each cDNA pool were
analyzed by PCR for the presence of alpha-tubulin transcripts.
Cycling conditions were: 2 min at 95uC, 28 cycles at (95uC for
45 s, 53uC for 45 s, 74uC for 1 min) and 74uC for 6 min. The
PCR amplification products from the different cDNA dilutions
were resolved on a 1% agarose gel, visualized on a KODAK
Image Station 2000R and gel images were captured using the
IS2000R Image Aquire Software (Eastman Kodak Co, Rochester
New York). The cDNA dilutions that resulted in PCR products of
equal intensity from the different tissue samples were identified
and all subsequent PCR reactions were performed using these
cDNA template dilutions.
All experimental reactions were performed using the cDNA
templates prepared as described above at 32 and 36 cycles for each
sample in duplicate. As controls, alpha-tubulin and BARP sequences
were amplified at 32 and 36 cycle reactions, respectively. Primer
sequences can be found in Table S1. All amplification products
were analyzed by electrophoresis and imaging as described above.
Genes that resulted in no amplification products or that yielded
multiple bands after amplification were excluded from further
analysis (Table S2). Expression analysis was repeated for genes that
yielded a product in only one tissue cDNA or for genes with
unclear results due to low levels of expression.
Quantifying gene expression levels
Gel images obtained from the 36 cycle reactions were used to
obtain a semi-quantitative measurement of expression variation
between different developmental samples. The values were
normalized to the trypanosome alpha-tubulin control to account
for variation between the four experimental tissue samples (SG,
PV, MG, and BSF) and experimental runs. The adjusted
expression values based on alpha-tubulin levels were used to
categorize the expression profile of experimental genes. Based on
these adjusted values, the fold change was calculated for the four
developmental samples tested, for each gene yielding expression
data. Where no expression could be detected, that transcript was
classified as not detected (nd). If expression in one tissue was at
least 2-fold higher than any other tissue, that gene was classified as
being specific to that tissue. Parasite gene expression was classified
as preferential for a tissue (or tissues) when gene expression was
detected but the levels were less than 2 fold higher than that
detected in other tissues. Genes with expression levels too low to be
confidently categorized, or with expression profiles not corre-
sponding to any other category were classified as miscellaneous.
Expression levels were classified as high, medium or low based on
the adjusted net intensities of the most prominent band for the
experimental gene. Net intensity values $501 were classified as
high, 101–500 as medium, and 0–100 as low. All expression data
are being submitted to TriTrypdb.org.
Quantitative RT-PCR
To validate the expression profiles observed with semi-
quantitative analysis, 5 genes were selected for quantitative RT-
PCR (qRT-PCR). Standard curves were developed for each gene
using serial dilutions of plasmids containing cloned inserts. Each
standard was used to calculate transcript numbers in the
experimental cDNAs tested. qRT-PCR primers and cycling
conditions are listed in Table S3. All reactions were performed
on an icycler iQ real time RT-PCR detection system (Bio-Rad).
Three independent biological replicates of infected SG, PV and
T. brucei Differential Gene Expression
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comparison to the quantitative data, the semi-quantitative fold
change data was evaluated based on the SG, PV, and MG data
points. As no BSF samples were evaluated by qRT-PCR, the semi-
quantitative data for the BSF parasites was excluded from this
comparison. Alpha-tubulin levels were used for expression normal-
ization. Values are represented as the mean fold change (6SEM)
and statistical significance was determined using a Student’s t test
implemented in Microsoft Excel software.
Results
The goal of this work was to determine the developmental and
host tissue specific expression profiles of transcripts corresponding
to previously undiscovered putative GPI-anchored proteins in T.
brucei. We describe the selection of the genes encoding such
predicted GPI-anchored proteins from the available T. b. brucei
genome sequence, and their differential expression during
development in tsetse tissues and the mammalian host as
determined by semi-quantitative analysis. Further, quantitative
expression analysis on a random subset of these genes validated the
semi-quantitative results.
In silico screen
An in silico analysis of the T. b. brucei strain 927 genome data
using the BigPI GPI-anchor prediction software identified 163
putative proteins with GPI anchor attachment motifs. Fifty-seven
of these gene products had known or predicted functions such as
BARP, GP63, trans-sialidase and the procyclin-associated genes, and
were excluded from further analysis (Table S4). The remaining
106 putative proteins were evaluated for the presence of conserved
domains (Table S5). These putative products were further
searched for glycosylation, signal peptide, and trans-membrane
domains, and a second predictive algorithm for GPI-anchor
attachment domain (FragAnchor) was applied (Table S6). Typical
GPI anchored proteins are expected to have a signal peptide and
no trans-membrane domains [26]. Our analysis reduced the initial
106 genes down to 25 genes, which were predicted to encode
products with GPI-anchor attachment motifs (Table 1).
Of the 25 highly probable GPI-anchored gene products with
unknown functions, only Tb09.142.0410 was considered to be
hypothetical, having no identified homologs. Two genes
(Tb927.4.3290 and Tb927.10.990) were shared only with Trypanosoma
congolense, while five others were conserved at the level of the TriTryp
genomes. Seventeen genes were identified to be members of larger
gene families. Interestingly, these were not widely shared between
related kinetoplastids. Only one family (Tb927.8.930 and Tb927.8.950)
had homologs outside of the T. brucei c o m p l e x ,a n dt h e s ew e r ef o u n di n
Trypanosoma vivax. The remaining gene family members were either
detected only as repeated genes in the genome of T. b. brucei (9), or as
having homologs in the genome of T. b. gambiense (6).
Developmental stage-regulated gene expression
assay. Semi-quantitative RT-PCR analysis was used to evaluate
the tissue and developmental stage-regulated expression of 81
genes, predicted to contain GPI-anchor attachment signals based
on Big PI analysis. The expression profile data were validated for 5
randomly selected genes using qRT-PCR analysis.
All transcripts were analyzed by PCR amplification using
normalized cDNA templates prepared from the MG, PV and SG
tissues microscopically confirmed to be infected with T. b. brucei,
and from BSF parasites obtained from infected rat blood. The
normalization process is described in the methods, and an example
is shown in Figure 1a. As controls, the cDNAs were also analyzed
for the presence of transcripts corresponding to two known stage-
regulated gene families, procyclin and BARP. Procyclin proteins are
expressed by trypanosomes infecting the tsetse MG and PV.
Accordingly, procyclin transcripts were detected only in cDNAs
from these tissues (Figure 1b). BARP has been shown to be
expressed only on the attached forms of trypanosomes in the SG
[4] and PCR amplification of experimental cDNAs similarly
demonstrated SG specific expression of this gene (Figure 1c).
The 5 genes which were randomly selected for qRT-PCR
validation included SG specific, PV preferential, MG specific and
miscellaneous genes, representing the high (1), medium (1), and
low (3) expression level categories. The qRT-PCR data for each of
these genes corresponded well to the semi-quantitative data
(Figure 2). Expression of the SG specific gene Tb927.8.950, was at
least 2-fold higher in the SG stages than in either the PV or MG
stages by qRT-PCR, corresponding well to the semi-quantitative
analysis. The quantitative and semi-quantitative data for the single
PV preferential gene, Tb927.3.2400, both showed the same trend
of high expression only by parasites in the PV, and the qRT-PCR
results showed transcript abundance in the PV and MG samples to
be significantly different. Similarly, both analyses yielded the same
results for the MG specific Tb927.5.4020. Finally, although they
were expressed at too low a level to be conclusively categorized by
semi-quantitative PCR analysis, the genes Tb927.10.5710 and
Tb927.10.5700 appeared to be SG specific based on both analyses.
Large standard deviations were observed with many of the salivary
gland qRT-PCR results, which are expected due to the individual
variability in parasite life stage proportions in infected salivary
glands. The strong correlation between the qRT-PCR and semi-
quantitative RT-PCR analyses for the selected genes validated the
semi-quantitative results indicating these data are representative of
the in vivo expression profile of the evaluated unknown genes.
Developmental stage-regulated expression of putative
GPI associated hypothetical proteins. We detected tran-
scripts from parasitized MG, PV and SG tissues for 59 of the 81
trypanosome genes analyzed. Expression data for the 38 genes
identified as ‘‘low likelihood of encoding GPI-anchored proteins’’
can be seen in Table S7. Expression data for the 25 genes
identified as ‘‘high likelihood of encoding GPI-anchored proteins,’’
can be seen in Table 2. Transcripts could be detected for only 21
of the 25 genes and strikingly, most of these genes (76.2%; 16/21)
were expressed by parasites infecting tsetse SG or PV tissues. If
expression of a gene in stages infecting one tissue was at least 2-fold
higher than expression levels measured in stages infecting another
tissue, that gene was classified as being specific to stages infecting
the former tissue. With that in mind, more than one-third of the
analyzed genes (38.1%, 8/21) were specifically expressed by SG
parasite stages (Table 2). Similarly, transcripts corresponding to
80% of the genes with ‘‘low likelihood of encoding GPI-anchored
proteins’’ were detected in SG and PV tissues (Table S7).
Relative gene expression levels were determined by net band
intensity (Table 2). With a single exception (Tb927.10.4390), only
SG stage-regulated trypanosome genes were highly expressed. An
equal number of genes (8) were expressed at low levels, with only a
small proportion of transcripts (5/21) being detected at moderate
levels (Table 2). Expression profiles, which were high in a
particular tissue, but were not 2 fold greater than that detected
in other tissues, were classified as preferential. Most of the genes
predicted to encode GPI-anchored proteins (8/9) were preferen-
tially expressed by parasites infecting SG or PV, while one
appeared to be constitutively expressed during development in the
tsetse host (Table 2, Figure 3). Seven of the 15 expressed genes
represented 3 different gene families in the T. brucei genome, while
1 gene (Tb09.211.4155) was found to be a single copy gene
conserved across the TriTryp genomes.
T. brucei Differential Gene Expression
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parasites in tsetse saliva. To further characterize the 8 SG
specific genes, their expression in metacyclic (MCF) parasites in
saliva and parasitized SG were evaluated by RT-PCR analysis.
Transcripts detected in parasitized SG could represent genes
expressed by the immature SG trypanosome stages, by both the
immature SG trypanosome stages and the vertebrate infective
MCF parasites, or by the MCF parasites free in tsetse saliva. In
contrast, transcripts detected in MCF samples specifically repre-
sent free forms in saliva. Transcripts corresponding to all 8
probable GPI-anchored proteins were detected in MCF cDNAs,
representing infective trypanosomes that are injected into the
mammalian host (Table 3).
Discussion
Here we report on the identification of T. brucei genes encoding
predicted unknown surface proteins obtained via in silico GPI-
anchor attachment signal sequence prediction analysis. Expression
profiling analysis from mammalian and tsetse developmental
stages indicate that transcripts for the majority of the hypothetical
and hypothetical conserved proteins are expressed in parasites
during their development in the tsetse salivary glands and
proventriculus. Most notably, we identified 8 trypanosome genes
specifically expressed in parasitized salivary glands, expression for
all of which was also detected from mammalian infective MCF
trypanosomes present in fly saliva. The results of this analysis give
the first large-scale insight into stage-regulated expression of genes
encoding putative hypothetical surface proteins during key
developmental processes in the tsetse fly, and support the
established paradigm of differential expression through develop-
ment. Functional characterization of these unknown proteins,
particularly expressed by metacyclics in saliva, ay lead the way to
novel transmission blocking strategies in the mammalian host.
Proteins with GPI posttranslational modification are typically
expressed on the surface of eukaryotic parasites and have the
potential to participate in important biological processes such as
cell–cell interactions, signal transduction, endocytosis, comple-
Table 1. Genes identified by in silico analysis of the T. brucei genome for predicted GPI-anchored proteins.
Tb ORF Kinetoplastid conservation
* GPI anchor prediction Signal Peptide
# Gly. Status
1
BigPI FragAnchor
Hypothetical Conserved
Tb927.3.2400 TriTryp x x x
Tb927.4.1110 TriTryp x x x N-gly
Tb927.4.3290 Tco x x x
Tb927.8.1250 TriTryp x x x N-gly
Tb09.211.2750 TriTryp x x x
Tb09.211.4155 TriTryp x x x
Tb927.10.990 Tco x x x N-gly
Gene Families
Tb927.6.1310 x x x N-gly
Tb927.7.360 x x x N-gly
Tb927.7.380 x x x N-gly
Tb927.7.400 x x x N-gly
Tb927.7.420 x x x N-gly
Tb927.7.440 Tbg x x x N-gly
Tb927.8.930 Tbg, Tv x x x N-gly
Tb927.8.950 Tbg, Tv x x x N-gly
Tb09.v1.0450 x x x N-gly
Tb09.v1.0470 x x x N-gly
Tb09.v1.0500 xx x
Tb09.v1.0530 xx x
Tb09.211.0010 Tbg x x x N-gly
Tb927.10.4390 Tbg x x x N- & O-gly
Tb927.10.4380 Tbg x x x N- & O-gly
Tb927.10.5700 Tbg x x x N-gly
Tb927.10.5710 Tbg x x x N-gly
Hypothetical
Tb09.142.0410 x x x O-gly
*TriTryp (T. brucei, T. cruzi, L. major); Tbg=T. brucei gambiense; Tco=T. congolense;T v=T. vivax.
#signal peptide and signal sequence cleavage prediction made by publically available software.
1N- or O-glycosylation status predicted by publically available software.
Conservation within the sequenced kinetoplastid genomes in addition to T. brucei and predicted features of the predicted protein are shown.
doi:10.1371/journal.pntd.0001708.t001
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parasites, GPI anchored glycoconjugates extensively coat the
plasma membrane and are involved in many aspects of host–
parasite interactions, such as adhesion and invasion of host cells,
modulation and evasion from host immune response [26]. As such,
there is interest in identifying the surface proteins of the medically
important kinetoplastids, as reported in L. (V.) braziliensis and T.
cruzi where proteomic techniques were applied to capture this class
of proteins [28–30]. Current knowledge of the VSGs and
procyclins, two of the best characterized GPI-anchored surface
proteins of T. brucei has demonstrated the importance of these
proteins in trypanosome developmental processes. Further, GPI
biosynthesis has also been implicated as a molecular target for
development of new drugs against African sleeping sickness
[31,32]. The availability of the T. brucei genome allows for
postgenomic discoveries including screens for hallmark motifs such
as GPI anchor attachment signals associated with surface proteins
[26].
Several publically available programs can be used to predict
post-translational modifications (PTM) such as glycosylation and
GPI-anchor attachment, although a gold standard for prediction
software remains to be found [33]. As a result, experimental
validation of predicted features is always warranted. The quality of
predictive algorithm outputs vary in response to several factors. In
the case of GPI-anchor prediction, variables include the size of the
motif recognized, quality of the underlying data used to test the
algorithm, and correct application of learning procedures such as
neural networks [34,35]. The ideal tool would have high sensitivity
to detect true positives, with a low false prediction rate [33–35].
Also relevant is the biological context being considered, as a result
there are algorithms specifically for protozoa, fungi, plants, etc
[34]. As seen with our dataset, two algorithms can generate
different results from the same dataset. In this work, FragAnchor
agreed with most, but not all of those genes previously identified
by a BigPI search specific for protozoa GPI anchor attachment
domains. A similar outcome with these two programs was reported
after testing both against known positive and negative control GPI-
anchored protein datasets [34], and against a dataset from the
protozoan pathogen Plasmodium falciparum [19]. In both of these
cases, although correct identification of true GPI-anchored
proteins was high, the false positive rate was high as well.
Conversely, another group found FragAnchor to be more accurate
than BigPI, while maintaining the same false positive rate [35],
although limitations associated with the algorithm they employed
for comparison make it difficult to draw clear conclusions [34].
With these challenges in mind, we opted for a conservative
approach in the identification of putative GPI-anchored proteins
by selecting only those genes encoding products that showed
agreement between the two predictive programs. As the absence of
predicted trans-membrane domains is necessary to support a
prediction of GPI-anchoring [26], we further excluded putative
proteins bearing any predicted trans-membrane domains from
expression analysis despite predictions of GPI-anchoring. While
the presence of a GPI anchor attachment signal suggests cell
surface membrane expression as mentioned earlier, there is
evidence that both N- and O- glycosylation status directs nascent
Figure 1. Expression profiling of three known genes from experimental cDNA templates. As experimental controls alpha-tubulin,
procyclin and BARP gene expression was analyzed A) alpha-tubulin,B )procyclin,C )BARP PCR amplified from infected tsetse salivary glands (lane 1),
proventriculus (lane 2), midguts (lane 3), and bloodstream form (lane 4) cDNAs.
doi:10.1371/journal.pntd.0001708.g001
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sites, glycosylation sites can be predicted using in silico methodol-
ogy. Importantly, while the presence of predicted glycosylation
sites support the expectation of surface expression, the absence of
glycosylation does not imply a lack of surface expression of a
protein [38].
Fifty-six of the in silico-identified genes in the T. b. brucei genome
had known or predicted functions in other closely related
Figure 2. Validation of semi-quantitative RT-PCR analysis. Fold-change expression was measured by qRT-PCR analysis for randomly selected
trypanosome genes in tsetse SG, PV, and MG tissues, relative to alpha-tubulin expression (bar graph). The values obtained by the semi-quantitative
fold-change analysis for the same genes are shown as numerical data below each graph. Tb927.10.5700/5710 are two related genes amplified by the
same primers. Asterisks (*) denote statistical significance (p#0.05), diamonds (¤) denote non-significant trend p#0.10.
doi:10.1371/journal.pntd.0001708.g002
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analysis. These included all members of the BARP family, and
many genes with putative functions, such as GP-63 surface protease (5
copies), trans-sialidase (4 copies), procyclin associated gene 4 (2 copies),
and numerous carrier or transporter proteins. Our aim was to
identify unknown SG stage-regulated genes for downstream
characterization and investigation as novel transmission blocking
targets. Of the 163 non-procyclin, non-VSG coding genes that
were identified as encoding GPI-anchor proteins using the BigPI
prediction software, 104 were confirmed with FragAnchor. With
regard to possible function of these gene products, 106/163 had
no known functions. A search of the available whole genome
sequence information from T. b. gambiense, L. major, T. cruzi, T.
congolense and T. vivax indicated that about 21% (22/106) of the
identified genes were unique to T. b. brucei. With regard to the 25
genes that met our criteria to be considered likely to encode
predicted GPI-anchored proteins, 5 were conserved at the level of
the TriTryp genomes, 10 were shared with other species of
Trypanosoma, and 10 were unique to T. b. brucei. It is possible that
the lack of homologs in these genomes reflects the different biology
of the parasite species, although it is also possible that as genome
annotations improve homologs may be revealed. While T. b.
gambiense is more closely related to T. b. brucei than the other
trypanosomatid species analyzed, its biology differs from T. b.
brucei. It remains to be seen if the unique genes in T. b. brucei
genome contribute to its differing epidemiology. The annotated
whole genome sequence of T. b. rhodesiense is not yet available,
however, the status of T. b. brucei specific genes in T. b. rhodesiense is
of interest both from an evolutionary and epidemiological point of
view.
Gene expression profiling analysis showed that the majority of
the 21 genes for which we detected transcripts, are expressed by
trypanosome developmental stages present in the tsetse fly PV and
SG tissues, while comparatively fewer are expressed by mamma-
lian bloodstream forms and none in the MG. A similar trend was
found in genes encoding proteins with less likelihood of GPI
anchoring. Similarly, a proteomic analysis that identified GPI-
anchored molecules in T. cruzi insect-stage epimastigote cultures
also found the majority of the identified proteins to be novel [30].
In the case of T. brucei, obtaining sufficient epimastigote and
metacyclic parasites from infected tsetse flies for functional analysis
is difficult since these stages are unculturable in vitro. Confirmation
of the corresponding stage-regulated protein expression is a
necessary next step, and the resulting data may shed light on the
roles of these products in parasite biology. Complex gene
expression profiles for putative surface proteins in the proven-
tricular and salivary gland stages of T. brucei may reflect the
multiple discrete trypanosome developmental stages infecting
these tissues, or heightened sensitivity of these trypanosomes to
the tsetse or mammalian bite-site host environment. Unlike the SG
and PV, far fewer unknown putative surface proteins were
associated with the BSF and MG stages. This minimal detection
of unknown transcripts in PF and BSF samples may be related to
the abundant expression of known GPI-anchored major surface
proteins in these stages- specifically the procyclins and VSGs,
respectively.
Interestingly, genes encoding 8 of the 21 putative GPI-anchored
proteins were specifically upregulated by parasites infecting tsetse
SG. Although trypanosomes undergo four distinct developmental
steps in this tissue, only two GPI-anchored protein families have
been demonstrated on the surface of any SG stages to date. The
alanine-rich BARP proteins are expressed on epimastigotes
attached to the salivary gland epithelium. Free metacyclics in
saliva no longer express BARP, but have upregulated the
metacyclic variant surface glycoproteins (M-VSGs) in advance of
inoculation into the mammalian host [17,39]. The data presented
here suggest a more complex series of events may be involved in
the maturation of the SG-inhabiting trypanosome stages. Proteins
specifically expressed on the immature SG stages might be
involved in host-parasite interactions and as such could be targeted
to prevent parasite maturation in the fly using genetic modification
strategies in the tsetse host [40]. On the other hand, proteins
expressed on the mature metacyclics may present novel vaccine
targets for use in the vertebrate hosts.
Importantly, transcripts corresponding to the SG stage-regulat-
ed genes were not detected in the bloodstream form stages. Since
the mammalian infective metacyclic trypomastigote is suggested to
be ‘‘pre-adapted’’ to life in the vertebrate host, one could expect
these samples to share proteins. There are two potential
explanations for this observation. First, many gene products
associated with adaptation to the vertebrate environment are likely
to be intracellular i.e. related to energy metabolism, and therefore
not bearing GPI-anchor attachment domains. As a result, these
genes are expected to have been excluded from the in silico screen
applied here. Second, when an infective fly bites the vertebrate
Table 2. Normalized stage-regulated gene expression
profiles and levels for predicted likely GPI anchored proteins.
Tb ORF SG6 PV6 MG6 BSF6
Expression
Level
N
SALIVARY GLAND SPECIFIC
Tb927.7.360/Tb927.7.380/Tb927.7.440 58 1 2 nd High
Tb927.7.400/Tb927.7.420 34 2 1 2 High
Tb927.6.1310 4 nd nd 1 High
Tb927.8.950 17 8 2 1 High
Tb09.211.4155 6 2 1 1 Medium
SALIVARY GLAND and PROVENTRICULUS PREFERENTIAL
Tb927.8.930 4 4 1 nd Medium
Tb09.142.0410 24 18 1 2 Medium
PROVENTRICULUS PREFERENTIAL
Tb927.3.2400 nd 5 1 nd Low
Tb927.4.1110 151 n dL o w
Tb09.211.0010 nd 1 nd nd Low
PROVENTRICULUS and BSF PREFERENTIAL
Tb927.10.4390 171 4 H i g h
Tb09.211.2750 3 6 1 5 Medium
Tb09.v1.0450 nd 1 nd 2 Low
INSECT PREFERENTIAL
Tb927.8.1250 3 2 2 1 Medium
CONSTITUTITIVE
Tb927.10.4380 123 1 L o w
MISCELLANEOUS
Tb927.10.5710/Tb927.10.5700 1n d n d n dL o w
Tb927.10.990 nd nd 1 nd Low
uSG=salivary gland, PV=proventriculus, MG=midgut, BSF=bloodstream form.
NExpression level was categorized based on artificial numerical values.
nd=not detected.
Relative expression levels of experimental genes were determined by
calculating relative band intensities for each PCR product relative to alpha-
tubulin expression in the same sample. Fold change was calculated based on
the value for the tissue with the lowest detectable expression for each gene.
doi:10.1371/journal.pntd.0001708.t002
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bloodstream forms being not apparent until nearly a week after the
infective bite [41,42]. Thus it is possible that transitional
metacyclics (t-MCFs), i.e. those detected in vertebrate blood in
the days immediately after an infective tsetse bite, but before
differentiation to the BSF, may have a transcriptome that reflects
the parasite adaptation process from the environment of inverte-
brate saliva to vertebrate blood.
MCF trypanosomes, like malarial sporozoites, are the critical
developmental stage of the parasite which gives rise to infection in
the vertebrate host. While considerable effort has been mounted
towards development of a sporozoite vaccine for the prevention of
malaria, this has not been the case with the MCF of T. brucei.T o
date, VSGs have effectively thwarted all attempts at developing a
vaccine against the mature BSF. It is thought that MCF parasites
also express variable proteins (M-VSGs), which would hamper
vaccine development efforts targeting MCF. Our results suggest
however that GPI-anchored surface protein repertoire of MCF
may be more complex and different from the BSF forms than
originally thought. The expression of the genes encoding putative
surface proteins on the mammalian-infective stage suggests a
complex interface of MCF and mammalian bite-site.
In summary, the in silico and semi-quantitative gene expression
analyses approach used here has allowed an important first look at
the stage-regulated expression of genes encoding putative GPI-
anchored proteins with no known functions in the human and
animal pathogen T. brucei. The findings presented here suggest that
the tsetse host-parasite interplay during differentiation may be
quite complex. Most importantly, these results greatly increase our
understanding of trypanosome biology at the point of transmission
to the vertebrate host, and identify a number of putative invariant
surface proteins, which could be investigated further for novel
transmission blocking strategies.
Supporting Information
Table S1 Gene specific primer pairs sequence used for RT-PCR
analysis*.
(DOC)
Table S2 Genes that were excluded from expression analysis.
(DOC)
Table S3 Gene specific qRT-PCR primer sequences used for
expression data validation. qRT-PCR primers were designed by
Beacon Designer
TM software (Premier Biosoft International, Palo
Alto, California), or the OligoPerfect
TM Designer primer design
tool. qRT-PCR cycling conditions were: 95uC for 8 min, 40 cycles
(95uC for 15 s, 30 s annealing, 72uC for 30 s), 95uC for 1 m, and
Figure 3. Tissue specificity of trypanosome gene expression. Percentage of trypanosome transcripts corresponding to putative probable GPI-
anchored proteins detected by semi-quantitative RT-PCR by expression profile classification.
doi:10.1371/journal.pntd.0001708.g003
Table 3. Salivary gland specific gene expression in metacyclic
trypanosomes in saliva.
Gene Identifier Metacyclic Transcripts
Tb927.7.360 +
Tb927.7.380 +
Tb927.7.440 +
Tb927.7.400/Tb927.7.420 +
Tb927.6.1310 +
Tb927.8.950 +
Tb09.211.4155 +
+=transcript detected.
Eight genes previously determined to be specifically expressed in salivary
glands were analyzed from metacyclic cDNAs by RT-PCR analysis.
doi:10.1371/journal.pntd.0001708.t003
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primer pair combination as shown.
(DOC)
Table S4 Gene products with known or predicted functions
identified by an in silico screen of the first published genome of T.
brucei using BigPI software (genes encoding VSG and ESAG
filtered out). The gene set was re-evaluated using a second
algorithm, FragAnchor, and agreement between the algorithms is
noted.
(DOC)
Table S5 Interpro domains detected from the 106 putative gene
products initially identified as encoding predicted GPI-anchored
protein retrieved from TriTrypDB. The location of the domain
within the CDS of the gene is listed. Genes from which no domain
was detected are excluded from this list.
(DOC)
Table S6 Bioinformatic analyses of the 81 putative genes that
had a lower likelihood of encoding GPI-anchored proteins. These
gene products either had TM domains, lacked signal peptide
domains, or were predicted by only one of the GPI anchor
prediction analysis. Forty-nine genes were conserved at the
TriTryp level, having orthologs in the T. cruzi and L. major
genomes. Twenty-one gene products had homologs identified in
the available genome sequences of other species of Trypanosoma (T.
cruzi, T. congolense, T. vivax,o rT. b. gambiense) but not in L. major.
Finally 12 genes examined were found to be present only in the
genome of T. b. brucei, but not in any related kinetoplastid.
(DOC)
Table S7 Developmental stage regulation and level of expression
of gene products that were predicted to be less likely to contain
GPI- anchor attachment signal domains.
(DOC)
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